Aimee R Kreimer
Overview
Explore the profile of Aimee R Kreimer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
5204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sierra M, Carvajal L, Dull P, Herrero R, Schussler J, Hildesheim A, et al.
Vaccine
. 2025 Feb;
50:126841.
PMID: 39961279
Background: New approaches to control HPV infections and prevent progression to cervical precancer are needed. We investigate the probability of viral clearance and progression to cervical precancer in women infected...
2.
Shing J, Giuliano A, Brenner N, Michels B, Hildesheim A, Srivastava S, et al.
J Natl Cancer Inst
. 2024 Dec;
PMID: 39658222
Background: Human papillomavirus (HPV)16-E6 seropositivity accurately predicts oropharyngeal squamous cell carcinoma (OPSCC) risk decades before diagnosis; but the biomarker's translational potential is unknown. To inform considerations for OPSCC screening, we...
3.
Kava C, Chaturvedi A, Senkomago V, Mix J, Markowitz L, Kreimer A, et al.
J Natl Cancer Inst
. 2024 Dec;
PMID: 39657945
In addition to oropharyngeal cancers, evidence suggests there may be an etiologic role for human papillomavirus (HPV) in some other head and neck cancers arising from the oral cavity and...
4.
Porras C, Romero B, Kemp T, Fantin R, Herrero R, Hildesheim A, et al.
J Natl Cancer Inst Monogr
. 2024 Nov;
2024(67):329-336.
PMID: 39529529
Background: The Costa Rica HPV Vaccine Trial provided initial evidence that 1 dose of the bivalent human papillomavirus (HPV) vaccine induces stabilizing antibody levels that may provide extended protection against...
5.
Kreimer A, Watson-Jones D, Kim J, Dull P
J Natl Cancer Inst Monogr
. 2024 Nov;
2024(67):313-316.
PMID: 39529520
Human papillomavirus (HPV) vaccines received regulatory approval and were recommended for use in young girls nearly 2 decades ago. Uptake is mostly high in resource-rich settings. In resource-limited settings, where...
6.
Slimovitch R, Shing J, Fantin R, Vanegas J, Porras C, Herrero R, et al.
Lancet Reg Health Am
. 2024 Sep;
38:100872.
PMID: 39280883
Background: There has been an increase in certain cancers among young adults (YA) aged 20-39, particularly in Latin America. This is the first study to examine cancer incidence and mortality...
7.
Dull P, Achilles S, Ahmed R, Barnabas R, Campos N, Chirgwin K, et al.
Vaccine
. 2024 Jul;
42(25):126100.
PMID: 39004526
Cervical cancer is a major cause of morbidity and mortality globally with a disproportionate impact on women in low- and middle-income countries. In 2021, the World Health Organization (WHO) called...
8.
Whitworth H, Mounier-Jack S, Choi E, Gallagher K, Howard N, Kelly H, et al.
Vaccine X
. 2024 Jun;
19:100486.
PMID: 38873638
Objectives: This study systematically reviewed the published literature from clinical trials on the efficacy and immunogenicity of single-dose HPV vaccination compared to multidose schedules or no HPV vaccination. Methods: Four...
9.
Shing J, Porras C, Pinheiro M, Herrero R, Hildesheim A, Liu D, et al.
NPJ Vaccines
. 2024 Jun;
9(1):101.
PMID: 38851816
The AS04-adjuvanted human papillomavirus (HPV)16/18 vaccine, an L1-based vaccine, provides strong vaccine efficacy (VE) against vaccine-targeted type infections, and partial cross-protection to phylogenetically-related types, which may be affected by variant-level...
10.
Kamuyu G, da Silva F, Tenet V, Schussler J, Godi A, Herrero R, et al.
Nat Commun
. 2024 Feb;
15(1):1608.
PMID: 38383518
Human Papillomavirus (HPV) type variants have been classified into lineages and sublineages based upon their whole genome sequence. Here we have examined the specificity of antibodies generated following natural infection...